We are live on ! Find out more
COEPW

Coeptis Therapeutics Warrants
COEPW

Delisted

COEPW was delisted on the 24th of April, 2026.

Back to rankings

17 hedge funds and large institutions have $1.77M invested in Coeptis Therapeutics Warrants in 2021 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

800% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 1

200% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 2

89% more funds holding

Funds holding: 9 → 17 (+8)

9% less capital invested

Capital invested by funds: $1.95M → $1.77M (-$176K)

Holders
17
Holders Change
+8
Holders Change %
+88.89%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
6
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$563K
2
Wells Fargo
Wells Fargo
California
+$143K
3
RCM
Rivernorth Capital Management
Florida
+$141K
4
PC
Periscope Capital
Ontario, Canada
+$123K
5
AA
AQR Arbitrage
Connecticut
+$122K

Top Sellers

Rank Fund Capital Flow
1
SCM
Shaolin Capital Management
Florida
-$255K
2
OCAM
Owl Creek Asset Management
New York
-$188K
3
WAM
Wolverine Asset Management
Illinois
-$8K
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
Radcliffe Capital Management
Pennsylvania
$732K +$70.3K +74,900 New
Citadel Advisors
2
Citadel Advisors
Florida
$261K +$563K +600,292 New
ICM
3
Ionic Capital Management
New York
$188K +$99.8K +106,303 +32%
BCM
4
Basso Capital Management
Connecticut
$129K +$116K +123,716 +70%
OCAM
5
Owl Creek Asset Management
New York
$84K -$188K -200,000 -51%
Wells Fargo
6
Wells Fargo
California
$66K +$143K +152,454 New
RCM
7
Rivernorth Capital Management
Florida
$65K +$141K +150,000 New
PC
8
Periscope Capital
Ontario, Canada
$59K +$123K +131,142 New
AA
9
AQR Arbitrage
Connecticut
$56K +$122K +130,000 New
SCM
10
Shaolin Capital Management
Florida
$45K -$255K -272,019 -72%
CAC
11
Cowen and Company
New York
$34K +$73.8K +78,675 New
Walleye Trading
12
Walleye Trading
New York
$25K +$7.51K +8,000 +16%
ES
13
Equitec Specialists
Illinois
$15K +$22.8K +24,280 +245%
KJHP
14
K.J. Harrison & Partners
Ontario, Canada
$7K +$14.2K +15,153 New
VF
15
Virtu Financial
New York
$5K +$10.1K +10,761 New
UBS Group
16
UBS Group
Switzerland
$3K +$6.18K +6,588 +1,984%
Walleye Capital
17
Walleye Capital
New York
$38 +$11.3K +12,000 +16%
WAM
18
Wolverine Asset Management
Illinois
– -$8K -6,321 Closed

COEPW Hedge Fund Activity: Q1 2021 in Review

17 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Coeptis Therapeutics Warrants (COEPW) for Q1 2021, worth a combined $1.77M — down 9% from $1.95M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new COEPW positions and 1 closed out — a net gain of 8 holders — while 6 added to existing stakes and 2 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $563K. The largest seller was Shaolin Capital Management, cutting an estimated $255K.

  • 17 institutional investors held Coeptis Therapeutics Warrants (COEPW) as of Q1 2021, up from 9 in Q4 2020.
  • Funds reported $1.77M of Coeptis Therapeutics Warrants stock for Q1 2021, down 9% quarter-over-quarter.
  • 9 funds opened new Coeptis Therapeutics Warrants positions in Q1 2021 and 1 closed out, a net change of +8 holders.
  • The largest Coeptis Therapeutics Warrants buyer in Q1 2021 was Citadel Advisors, an estimated $563K added.
  • The largest Coeptis Therapeutics Warrants seller in Q1 2021 was Shaolin Capital Management, an estimated $255K sold.

Based on aggregated 13F filings for Q1 2021.